Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease

American Journal of Nephrology

Volumn 36, Issue 4, 2012, Pages 362-370

  Helal, Imed ^a   Reed, Berenice ^a   Mettler, Pamela ^a   Mc Fann, Kim ^a   Tkachenko, Oleksandra ^a   Yan, Xiang Dong ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Autosomal dominant polycystic kidney disease; Cardiovascular events; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASODILATOR AGENT;

ADULT; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; CARDIOMEGALY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; SMOKING; VALVULAR HEART DISEASE;

ADULT; AGED; ANEURYSM; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; DATA COLLECTION; DIABETES MELLITUS; FEMALE; HEART VALVE DISEASES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE; RISK FACTORS; SMOKING; STROKE;

EID: 84866933271     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000343281     Document Type: Review

References (49)

1. McCullough PA: Scope of cardiovascular complications in patients with kidney disease. Ethn Dis 2002; 12: 44-48.
2. U.S. Renal Data System: USRDS, 2011 Annual Data Report, 2011.
3. Schrier RW: Optimal care of autosomal dominant polycystic kidney disease patients. Nephrology 2006; 11: 124-130.
4. Ecder T, Schrier RW: Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 2009; 5: 221-228.
5. Florijin KW, Noteboom WM, Van Saase JL, Chang PC, Breuning MH, Vandenbroucke JP: A century of mortality in five large families with polycystic kidney disease. Am J Kidney Dis 1995; 25: 370-374.
6. Fick GM, Johnson AM, Hammond WS, Gabow PA: Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995; 5: 2048-2056.
7. Schrier RW, McFann KK, Johnson AM: Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 2003; 63: 678-685.
8. Patch C, Charlton J, Roderick PJ, Gulliford MC: Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population- based study. Am J Kidney Dis 2011; 57: 856-862.
9. Orskov B, Roømming Soørensen V, Feldt-Rasmussen B, Strandgaard S: Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark. Clin J Am Soc Nephrol 2010; 5: 2034-2039.
10. Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Chapman AB, Gabow PA, Schrier RW: Diuretics versus angiotensinconverting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol 2001; 21: 98-103.
11. Iglesias C, Torres V, Offord K, Holley K, Beard C, Kurland L: Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983; 2: 630 -639.
12. Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992; 41: 1311-1319.
13. Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E: Elevated blood pressure profile and left ventricular mass in children and young adults with adult polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1451-1457.
14. Chapman AB, Schrier RW: Pathogenesis of hypertension in autosomal dominant polycystic kidney disease. Semin Nephrol 1991; 11: 653-660.
15. Ecder T, Schrier RW: Hypertension in autosomal- dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol 2001; 12: 194-200.
16. Schrier RW, Johnson AM, McFann K, Chapman AB: The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomaldominant polycystic kidney disease. Kidney Int 2003; 64: 1792-1799.
17. Milutinovic J, Fialkow PJ, Agodoa LY, Phillips PA, Rudd TG, Bryant JI: Adult polycystic kidney disease symptoms and clinical findings. Q J Med 1984; 53: 511-522.
18. Chapman AB, Torres VE, Perrone RD, Steinman TI, Bae KT, Miller JP, Miskulin DC, Rahbari Oskoui F, Masoumi A, Hogan MC, Winklhofer FT, Braun W, Thompson PA, Meyers CM, Kelleher C, Schrier RW: The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol 2010; 5: 102-109.
19. Chaveau D, Pirson Y, Verellen-Dumoulin C, Macnicol A, Gonzalo A, Grunfeld JP: Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 1994; 45: 1140-1146.
20. Pietrzak-Nowacka M, Safranow K, Byra E, Bińczak-Kuleta A, Ciechanowicz A, Ciechanowski K: Metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease. Kidney Blood Press Res 2009; 32: 405-410.
21. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relationship of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
22. Chapman AA: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1997; 8: 1292-1297.
23. Saggar-Malik A, Missouris CG, Gill JS, Singer DR, Markandu ND, MacGregor GA: Left ventricular mass In normotensive subjects with autosomal dominant polycystic kidney disease. BMJ 1994; 309: 1617-1618.
24. Bardaji A, Vea AM, Gutierrez C, Ridao C, Richart C, Oliver JA: Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 1998; 32: 970-975.
25. Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT, HALT PKD Study Group, Meyers CM: Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2508-2515.
26. Ivy DD, Shaffer EM, Johnson AM, Kimberling WJ, Dobin A, Gabow PA: Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995; 5: 2032-2036.
27. Bardaji A, Martinez-Vea A, Valero A, Gutierrez C, Garcia C, Ridao C, Oliver JA, Richart C: Cardiac involvement in autosomal dominant polycystic kidney disease: a hypertensive heart disease. Clin Nephrol 2002; 56: 211-220.
28. Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW: Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension. Kidney Int 2008; 74: 1192-1196.
29. Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW: Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1999; 14: 1113-1116.
30. Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison L: Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal- dominant polycystic kidney disease: results of a seven-year prospective randomized study. J Am Soc Nephrol 2002; 13: 1733-1739.
31. Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA: Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 907-912.
32. Pirson Y, Christophe JL, Goffin E: Outcome of renal replacement therapy in adult polycystic kidney disease. Nephrol Dial Transplant 1996; 11: 24-28.
33. Ritz E, Zeier M, Schneider P, Jones E: Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn? Nephron 1994; 66: 125-128.
34. Verdalles U, Abad S, Vega A, Ruiz Caro C, Ampuero J, Jofre R, Lopez-Gomez JM: Factors related to the absence of anemia in hemodialysis patients. Blood Purif 2011; 32: 69-74.
35. Chapman AB, Rubinstein D, Hughes R, Stears JC, Earnest MP, Johnson AM, Gabow PA, Kaehny WD: Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992; 327: 916-920.
36. Ruggleri PM, Poulos N, Masaryk TJ, Ross JS, Obuchowski NA, Awad IA, Braun WE, Nally J, Lewin JS, Modic MT: Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology 1994; 191: 33-39.
37. Hadimeri H, Lamm C, Nyberg G: Coronary aneurysms in patients with adult polycystic kidney disease. J Am Soc Nephrol 1998; 9: 837-841.
38. Montoliu J, Torras A, Revert L: Polycystic kidneys and abdominal aortic aneurysms. Lancet 1980; 1: 1133-1134.
39. Chapman AB & Hilson AJW: Polycystic kidneys and abdominal aortic aneurysms. Lancet 1980; 1: 646-647.
40. Torra R, Nicolau C, Badenas C, Brú C, Pérez L, Estivill X, Darnell A: Abdominal aortic aneurysms and adult polycystic kidney disease. J Am Soc Nephrol 1996; 7: 2483-2486.
41. Huston J, Torres VE, Sullivan PP, Offord KP, Wiebers DO: Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1871-1877.
42. Konoshita T, Okamoto K, Koni I, Mabuchi H: Clinical characteristics of polycystic kidney disease with end-stage renal disease. Clin Nephrol 1998; 50: 113-118.
43. Christophe JL, Van Ypersele de Strihou C, Pirson Y: Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. Nephrol Dial Transplant 1996; 11: 1271-1276.
44. Zeier M, Geberth S, Ritz E, Jaeger T, Waldherr R: Autosomal dominant polycystic kidney disease -clinical problems. Nephron 1988; 49: 177-183.
45. Schievink WI, Torres VE, Piepgras DG, Wiebers DO: Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1992; 3: 88-95.
46. Wiebers DO, Torres VE: Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992; 327: 953-955.
47. Xu HW, Yu SQ, Mei CL, Li MH: Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 2011; 42: 204-206.
48. Irazabal MV, Huston J 3rd, Kubly V, Rossetti S, Sundsbak JL, Hogan MC, Harris PC, Brown RD Jr, Torres VE: Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1274-1285.
49. Sarnak MJ: Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003; 41: 11-17.